Two of those – Xadago (safinamide) and Apokyn (apomorphine HCl) – are for Parkinson's ... Pacira already sells post-surgical painkiller Exparel (bupivacaine liposome injectable suspension ...

Bupivacaine Hydrochloride In Dextrose Injection manufactured by Aishwarya Healthcare, Montelukast and Levocetirizine Tablet (Dumont-L ) manufactured by Hygeia Pharmaceuticals, Nitrazepam Tablets ...

HCL Tech expects its revenue growth in the financial year 2026 to range between 2 per cent and 5 per cent. (Photo: Reuters) HCL Technologies is all set to announce its Q4FY25 results on today ...

There was a reduction of headcount by 7,398 individuals due to divesture while HCL Tech added 7,829 freshers to its roster. During the quarter, HCL Tech said that it added 2,665 employees to its ...

HCL Technologies shares surged 7.68 per cent to ₹1,593.60 at 11.35 on the NSE on Wednesday, following its Q4 results announcement and optimistic FY26 guidance that outpaced industry peers.

HCL Technologies announced its January-March quarter results for fiscal 2024-25 (Q4FY25) on Tuesday, April 22, and declared that its attrition rate has dropped to 13 per cent sequentially. The ...

Q4 results 2025: The earnings season has finally kicked as more than 100 companies including several marquee companies are scheduled to release their financial results for the quarter ended on ...

The body naturally produces a digestive acid called hydrochloric acid (HCL). This acid plays a vital role in breaking down food and absorbing nutrients. However, as we grow older, HCL production ...

Numbers reported by India’s top-tier IT companies for Q4 and full year FY25 reiterate that they are at an inflection point. Even a decade ago, the business outsourcing opportunity for Indian IT ...

In the study by Choi et al., [16] the group receiving the highest naloxone hydrochloride dosage (0.167 μg/kg/hr) had significantly lower VAS pain scores than the group receiving morphine alone.

Hospitals and clinics should plan to spend 11% to 13% and 2% to 4% more, respectively, for prescription drugs in 2025 compared to last year, according to new research. For the second consecutive ...